CARDIFF ONCOLOGY, INC. (CRDF) Capital expenditures 2016–2025
CARDIFF ONCOLOGY, INC. (CRDF) annual capital expenditure history — cash spent on property, plant and equipment, per SEC filings.
$44,000FY2025 · since FY2016: $823,483 → $44,000
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $44,000 | -45.0% |
| FY2024 | $80,000 | -86.3% |
| FY2023 | $582,000 | -42.1% |
| FY2022 | $1.0M | +390.7% |
| FY2021 | $205,000 | -2.8% |
| FY2020 | $211,000 | +212.0% |
| FY2019 | $67,622 | +1225.9% |
| FY2018 | $5,100 | -95.0% |
| FY2017 | $101,101 | -87.7% |
| FY2016 | $823,483 | — |
Capital expenditures are shown as the positive cash amount spent, as reported on the cash-flow statement.
Source: SEC XBRL filings · For reference only · Not investment advice